Renal retention of lipid microbubbles: a potential mechanism for flank discomfort during ultrasound contrast administration.

[1]  B. Haraldsson,et al.  The glomerular endothelium: new insights on function and structure , 2012, Current opinion in nephrology and hypertension.

[2]  M. Bader,et al.  Impaired Nociception and Peripheral Opioid Antinociception in Mice Lacking Both Kinin B1 and B2 Receptors , 2012, Anesthesiology.

[3]  Yechezkel Barenholz,et al.  Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: prediction and prevention. , 2011, Advanced drug delivery reviews.

[4]  M. Main.  Ultrasound contrast agent safety: from anecdote to evidence. , 2009, JACC Cardiovascular Imaging.

[5]  Stuart Moir,et al.  Safety of contrast agent use during stress echocardiography: a 4-year experience from a single-center cohort study of 26,774 patients. , 2009, JACC. Cardiovascular imaging.

[6]  R. Grimm,et al.  The safety of deFinity and Optison for ultrasound image enhancement: a retrospective analysis of 78,383 administered contrast doses. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[7]  Wuding Zhou,et al.  New boundaries for complement in renal disease. , 2008, Journal of the American Society of Nephrology : JASN.

[8]  C. Stefanadis,et al.  Safety of myocardial flash-contrast echocardiography in combination with dobutamine stress testing for the detection of ischaemia in 5250 studies , 2008, Heart.

[9]  Jonathan R Lindner,et al.  High-resolution myocardial perfusion imaging in mice with high-frequency echocardiographic detection of a depot contrast agent. , 2007, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[10]  Fuminori Moriyasu,et al.  Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. , 2007, Ultrasound in medicine & biology.

[11]  S. Radio,et al.  The role of complement in the adherence of microbubbles to dysfunctional arterial endothelium and atherosclerotic plaque. , 2007, Cardiovascular research.

[12]  L. Bolondi,et al.  The safety of Sonovue in abdominal applications: retrospective analysis of 23188 investigations. , 2006, Ultrasound in medicine & biology.

[13]  Janos Szebeni,et al.  Complement activation-related pseudoallergy: a new class of drug-induced acute immune toxicity. , 2005, Toxicology.

[14]  O. V. Evgenov,et al.  NOS3 deficiency augments hypoxic pulmonary vasoconstriction and enhances systemic oxygenation during one-lung ventilation in mice. , 2005, Journal of applied physiology.

[15]  B. Haraldsson,et al.  Glomerular size and charge selectivity in the mouse after exposure to glucosaminoglycan-degrading enzymes. , 2003, Journal of the American Society of Nephrology : JASN.

[16]  L. D. Nelson,et al.  Triad of acute infusion-related reactions associated with liposomal amphotericin B: analysis of clinical and epidemiological characteristics. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[17]  T. Skotland,et al.  Hepatic clearance of Sonazoid perfluorobutane microbubbles by Kupffer cells does not reduce the ability of liver to phagocytose or degrade albumin microspheres , 2003, Cell and Tissue Research.

[18]  S. Kaul,et al.  Influence of microbubble surface charge on capillary transit and myocardial contrast enhancement. , 2002, Journal of the American College of Cardiology.

[19]  Jiri Sklenar,et al.  Microvascular rheology of Definity microbubbles after intra-arterial and intravenous administration. , 2002, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[20]  S. Kaul,et al.  Noninvasive Imaging of Myocardial Reperfusion Injury Using Leukocyte-Targeted Contrast Echocardiography , 2002, Circulation.

[21]  S. Kaul,et al.  Noninvasive Ultrasound Imaging of Inflammation Using Microbubbles Targeted to Activated Leukocytes , 2000, Circulation.

[22]  J. Gottdiener,et al.  Efficacy and safety of the novel ultrasound contrast agent perflutren (definity) in patients with suboptimal baseline left ventricular echocardiographic images. , 2000, The American journal of cardiology.

[23]  S. Kaul,et al.  Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles. , 2000, Circulation.

[24]  S. Kaul,et al.  Microbubble persistence in the microcirculation during ischemia/reperfusion and inflammation is caused by integrin- and complement-mediated adherence to activated leukocytes. , 2000, Circulation.

[25]  A R Jayaweera,et al.  Albumin microbubble persistence during myocardial contrast echocardiography is associated with microvascular endothelial glycocalyx damage. , 1998, Circulation.

[26]  S. Kaul,et al.  In vivo myocardial kinetics of air-filled albumin microbubbles during myocardial contrast echocardiography. Comparison with radiolabeled red blood cells. , 1994, Circulation research.

[27]  D. Devine,et al.  Liposome-complement interactions in rat serum: implications for liposome survival studies. , 1994, Biochimica et biophysica acta.

[28]  J. Nyengaard,et al.  Number and dimensions of rat glomerular capillaries in normal development and after nephrectomy. , 1993, Kidney international.

[29]  B. Haraldsson,et al.  Morphological and functional evidence for an important role of the endothelial cell glycocalyx in the glomerular barrier. , 2006, American journal of physiology. Renal physiology.

[30]  M. Ng.  Electrophysiological characteristics of renal sensory receptors and afferent renal nerves , 1989 .

[31]  N. Moss.  Electrophysiological characteristics of renal sensory receptors and afferent renal nerves. , 1989, Mineral and electrolyte metabolism.